• Identifying and adding value to novel university-based medical technologies for diagnosis and treatment of disease
• Currently focused in the area of gastrointestinal diseases
• Emerging as a leader in colorectal cancer detection and therapy
• Developing highly sensitive markers for detecting colorectal cancer cells in tissue lymph nodes and blood
• Committed to research and development which will make a difference to the lives of patients, their families and the healthcare professionals who treat them
• Committed to scientific innovation, improving patient care, development of human resources, partnerships and responsible business practices

Current activities include:

• Establishment of a clinical laboratory for testing blood and tissue for metastatic colorectal cancer for patients and their physicians worldwide
• Ongoing research and development projects in:

  • In vitro Diagnostics
  • In vivo imaging agents
  • Receptor-based therapeutics
  • Cancer vaccines